Tags
You are here: Home
Prosonix
Prosonix Succesfully Scales Up Umax Technology For Respiratory Medicines
Prosonix has announced the successful scale up of UMAX, its new particle engineering technology that is set to revolutionize respiratory medicine. The scaleup has now been demonstrated on multiple APIs in GMP facilities. more
New Technology for Respiratory Medicines
Prosonix, Oxford/UK, has launched UMAX, a new disruptive particle engineering technology to be used in respiratory medicine. The proprietary technology delivers unique crystalline, excipient free, highly performing, stable drug particles, that offer significant and distinct and quantifiable advantages over current industry practice, and now enables the development and optimisation of a wide range of mono and combination inhalation therapies independent of delivery platform or device. more
Making Better Medicines
Enabling Technologies - Prosonix, the leading company in proprietary pharmaceutical ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions leverages its intellectual property and sonoprocessing equipment to deliver sustainable value to customers. more- Legal
- Help
- Participate
- Related Publications